A study to assess zibotentan pharmacokinetics in participants with moderate hepatic and moderate renal impairment
|Start Date:||November 2021|
|Primary Completion Date:
|Study Completion Date:
||Kidney Diseases; Liver, Pancreas & Gallbladder - Other|
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Stay informed about new Trial Results Summaries with our email notification service
|BG|| Sofia, BG, 1612|